Coming Up On US FDA’s User Fee Calendar: Zynteglo Approval Kicks Off Busy Season For Advanced Biologics, Pediatrics

 
• By Bridget Silverman
Stem cells
Is the FDA's approval of a new stem cell treatment a harbinger of more approvals in the coming weeks? • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers